EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Protective Effect and Mechanism of Rosiglitazone in α‐amanitin‐induced Hepatotoxicity Via Activation of PPAR‐γ/Nrf2 Signaling Pathway

Fuping Lai, Ya Liao, Jin Wu, Tinggang Wang, Guiyi Zhang, Xiaojun Zhang, Caiyun Xia, Jie Hu iD, Yuanlan Lu iD

Journal of Biochemical and Molecular Toxicology · 2026-02 · 40 (2)

DOI: 10.1002/jbt.70701 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 20.01.2026. Verfasst von Fuping Lai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Department, The Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, PPAR gamma, Signal Transduction, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zunyi United Fund Project HZ Zi (2023), National Natural Science Foundation of China, Guizhou Province Clinical Research Center for Emergency Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

α‐amanitin (α‐AMA), the primary lethal toxin of amanita, primarily targets the liver with a high toxicity and a low lethal dose. As the precise mechanism of intoxication is unclear, and specific antidotes are lacking, α‐AMA‐induced liver injury has a high mortality rate. As a selective PPAR‐γ agonist, Rosiglitazone (RSG) alleviates liver injury by upregulating the PPAR‐γ/Nrf2 signaling pathway, thereby enhancing antioxidant effects, mitigating inflammation, and reducing apoptosis. This study investigated the protective role and mechanism of action of RSG in α‐AMA‐induced acute liver injury in ICR mice. We established an experimental model and examined hepatic injury markers, focusing on PPAR‐γ/Nrf2 pathway activation. Overall, α‐AMA intoxication led to dose‐dependent increases in serum ALT/AST levels, accompanied by hepatocellular necrosis. This was associated with the onset of oxidative stress, characterized by the accumulation of malondialdehyde (MDA), excessive ROS production, and reduced activities of the antioxidant enzymes superoxide dismutase (SOD) and catalase (CAT). Furthermore, we observed the upregulation of pro‐inflammatory mediators (TNF‐α, IL‐6, and IL‐8), suppression of the PPAR‐γ/Nrf2 cytoprotective axis, and hepatocyte apoptosis induced via activation of the P53/caspase‐3 pathway, ultimately resulting in murine mortality. RSG treatment alleviated oxidative stress and the inflammatory response, reduced hepatocellular necrosis and apoptosis, and improved survival rates in α‐AMA‐intoxicated mice by upregulating the PPAR‐γ/Nrf2 signaling pathway in hepatocytes. Early RSG intervention can thereby effectively mitigate α‐AMA‐induced acute liver injury by upregulating the PPAR‐γ/Nrf2 signaling pathway. Future studies should focus on exploring the clinical potential of RSG as a therapeutic agent for amanita mushroom poisoning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2PPAR gammaSignal TransductionChemical and Drug Induced Liver InjuryRosiglitazoneAlpha-AmanitinAnimalsMice, Inbred ICRMiceMalePPAR-gamma AgonistsOxidative StressLiverApoptosis

Stichwörter der Autor:innen

PPAR‐γ/Nrf2 signaling pathwaysRosiglitazoneliver injuryoxidative stressα‐amanitin

Substanzen

NF-E2-Related Factor 2PPAR gammaRosiglitazoneNfe2l2 protein, mouseAlpha-AmanitinPPAR-gamma AgonistsPparg protein, mouse

Autor:innen und Institutionen

  • Emergency Department, The Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
  • Emergency Department, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, China.

ORCID-Profile: Jie Hu, Yuanlan Lu

Förderung

  • Zunyi United Fund Project HZ Zi (2023)
  • National Natural Science Foundation of China
  • Guizhou Province Clinical Research Center for Emergency Medicine
  • Guizhou Provincial Key Technology R&D Program-ZK
  • Startup Fund for scientific research, Fujian Medical University

Zitieren

APA

Lai, F., Liao, Y., Wu, J., Wang, T., Zhang, G., Zhang, X., Xia, C., Hu, J., & Lu, Y. (2026). Protective Effect and Mechanism of Rosiglitazone in α‐amanitin‐induced Hepatotoxicity Via Activation of PPAR‐γ/Nrf2 Signaling Pathway. Journal of Biochemical and Molecular Toxicology, 40(2). https://doi.org/10.1002/jbt.70701

Vancouver

Lai F, Liao Y, Wu J, Wang T, Zhang G, Zhang X, et al. Protective Effect and Mechanism of Rosiglitazone in α‐amanitin‐induced Hepatotoxicity Via Activation of PPAR‐γ/Nrf2 Signaling Pathway. Journal of Biochemical and Molecular Toxicology. 2026;40(2). doi:10.1002/jbt.70701

BibTeX
@article{Lai2026,
  author = {Lai, Fuping and Liao, Ya and Wu, Jin and Wang, Tinggang and Zhang, Guiyi and Zhang, Xiaojun and Xia, Caiyun and Hu, Jie and Lu, Yuanlan},
  title = {Protective Effect and Mechanism of Rosiglitazone in α‐amanitin‐induced Hepatotoxicity Via Activation of PPAR‐γ/Nrf2 Signaling Pathway},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  volume = {40},
  number = {2},
  doi = {10.1002/jbt.70701}
}
Kostenlos starten →